A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease Article (Faculty180)

cited authors

  • Bhatt, V R; Shostrom, V K; Choe, H K; Hamilton, B K; Gundabolu, K; Maness, L J; Kumar, V; Mahato, R I; Smith, L M; Nishihori, T; Lee, S J

authors

published in